Concepedia

Paul Martorano

PM

Statistics

Publications

6

Citations

179

H-Index

6

Active since

2019

Affiliations

University of Pennsylvania(Current)

Children's Hospital of Philadelphia

Cancer Research Center

Paul Martorano is an author at University of Pennsylvania specializing in medicine, pharmacology, and oncology.

Publications per year

2019–2022

6

Publications

6

PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma

Hannah Dabagian, Tahereh Taghvaee, Paul Martorano et al. · ACS Pharmacology & Translational Science · 2021 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

PARP-1–Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma

Hwan Lee, Aladdin Riad, Paul Martorano et al. · Journal of Nuclear Medicine · 2019 · 38 citations · Full text

Medicine, Oncology, Radiation Oncology +17

PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response

Aladdin Riad, Sarah B. Gitto, Hwan Lee et al. · Molecules · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

Vandana Batra, Minu Samanta, Mehran Makvandi et al. · Clinical Cancer Research · 2022 · 30 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Mehran Makvandi, Minu Samanta, Paul Martorano et al. · Communications Biology · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 6